SCHEMBL481607

SCHEMBL481607

CC(C)c1ccccc1C(C)(C)OOC(C)(C)c1ccccc1C(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.44
CYP3A4 P08684 2/20 0.43
ALDH1A1 P00352 2/20 0.43
CYP2C19 P33261 1/20 0.43
GABRA1 P14867 3/20 0.43
GABRB2 P47870 2/20 0.43
GABRG2 P18507 2/20 0.39
GABRB3 P28472 2/20 0.39
FAAH O00519 2/20 0.39
TSHR P16473 2/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
LMNA P02545 1/20 0.39
CYP1A2 P05177 1/20 0.39
HPGD P15428 1/20 0.39
GABRB1 P18505 1/20 0.39
PTGS1 P23219 1/20 0.39
SLC6A2 P23975 1/20 0.39
HTR2C P28335 1/20 0.39
GABRA5 P31644 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29578995 1.00 MAPK1 (0.44) MAPK1CYP3A4ALDH1A1CYP2C19GABRA1
SCHEMBL481583 0.94 GABRA1 (0.40) MAPK1CYP3A4ALDH1A1CYP2C19GABRA1
SCHEMBL28267963 0.88 CYP3A4 (0.39) MAPK1CYP3A4ALDH1A1CYP2C19GABRA1
SCHEMBL28406861 0.86 CYP3A4 (0.38) MAPK1CYP3A4ALDH1A1CYP2C19GABRA1
SCHEMBL13439643 0.84 CYP3A4 (0.42) MAPK1CYP3A4ALDH1A1CYP2C19GABRA1
SCHEMBL1318694 0.83 CYP3A4 (0.41) MAPK1CYP3A4ALDH1A1CYP2C19GABRA1
SCHEMBL362548 0.83 ALDH1A1 (0.48) CYP3A4ALDH1A1CYP2C19GABRA1GABRB2
SCHEMBL29449728 0.83 ALDH1A1 (0.48) CYP3A4ALDH1A1CYP2C19GABRA1GABRB2
SCHEMBL13408172 0.83 CYP3A4 (0.41) MAPK1CYP3A4ALDH1A1CYP2C19GABRA1
SCHEMBL2026303 0.82 GABRA1 (0.38) MAPK1CYP3A4ALDH1A1CYP2C19GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 538 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12637550-B2 Prepreg and uses thereof TAIWAN UNION TECHNOLOGY CORPORATION (TW) 2026-05-26 US claimed
US-12479988-B2 Resin composition and uses thereof TAIWAN UNION TECHNOLOGY CORPORATION (TW) 2025-11-25 US claimed
US-12428550-B2 Resin composition and uses thereof TAIWAN UNION TECHNOLOGY CORPORATION (TW) 2025-09-30 US claimed
US-20250129242-A1 RESIN COMPOSITION AND USES OF THE SAME TAIWAN UNION TECHNOLOGY CORPORATION (TW) 2025-04-24 US claimed
EP-4458898-A1 POLYETHYLENE BLEND COMPOSITION Dow Global Technologies Llc (US) 2024-11-06 EP claimed
US-20240301189-A1 RESIN COMPOSITION AND USES THEREOF TAIWAN UNION TECHNOLOGY CORPORATION (TW) 2024-09-12 US claimed
EP-3615608-B1 POLYETHYLENE BLEND COMPOSITION DOW GLOBAL TECHNOLOGIES LLC (US) 2024-07-17 EP claimed
US-20240150532-A1 PREPREG AND USES THEREOF TAIWAN UNION TECHNOLOGY CORPORATION (TW) 2024-05-09 US claimed
US-20240150567-A1 RESIN COMPOSITION AND USES THEREOF TAIWAN UNION TECHNOLOGY CORPORATION (TW) 2024-05-09 US claimed
US-20240084063-A1 SOLVENT-FREE RESIN COMPOSITION AND USES OF THE SAME TAIWAN UNION TECHNOLOGY CORPORATION (TW) 2024-03-14 US claimed
US-20190106557-A1 CROSSLINKABLE POLYMERIC COMPOSITIONS WITH METHYL-RADICAL SCAVENGERS AND ARTICLES MADE THEREFROM DOW GLOBAL TECHNOLOGIES LLC (US) 2019-04-11 US claimed
CN-109071952-A Crosslinkable polymeric composition with methyl free radicals scavenger and the article being made from it 陶氏环球技术有限责任公司 2018-12-21 CN claimed
WO-2018200319-A1 POLYETHYLENE BLEND COMPOSITION DOW GLOBAL TECHNOLOGIES LLC (US) 2018-11-01 WO claimed
WO-2018160403-A1 ETHYLENE-ALPHA-OLEFIN COPOLYMER-TRIALLYL PHOSPHATE COMPOSITION DOW GLOBAL TECHNOLOGIES LLC (US) 2018-09-07 WO claimed
WO-2018160402-A1 ETHYLENE-ALPHA-OLEFIN COPOLYMER-TRIALLYL PHOSPHATE COMPOSITION DOW GLOBAL TECHNOLOGIES LLC (US) 2018-09-07 WO claimed
US-20180247730-A1 ETHYLENE-UNSATURATED CARBOXYLIC ESTER COPOLYMER-TRIALLYL PHOSPHATE COMPOSITION DOW GLOBAL TECHNOLOGIES LLC (US) 2018-08-30 US claimed
US-20180247729-A1 ETHYLENE-UNSATURATED CARBOXYLIC ESTER COPOLYMER-TRIALLYL PHOSPHATE COMPOSITION DOW GLOBAL TECHNOLOGIES LLC (US) 2018-08-30 US claimed
EP-2938669-A1 CROSS-LINKABLE POLYMERIC COMPOSITIONS, METHODS FOR MAKING THE SAME, AND ARTICLES MADE THEREFROM Dow Global Technologies LLC (US) 2015-11-04 EP claimed
WO-2014101151-A1 CROSS-LINKABLE POLYMERIC COMPOSITIONS, METHODS FOR MAKING THE SAME, AND ARTICLES MADE THEREFROM DOW GLOBAL TECHNOLOGIES LLC (US) 2014-07-03 WO claimed
US-4202790-A USED IN CROSSLINKING POLYMERS SUCH AS POLYETHYLENE HERCULES INCORPORATED (US) 1980-05-13 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12637550-B2 Prepreg and uses thereof WDR33, C9, WDR36 MAPK1 2888/4885CYP3A4 1034/4885ALDH1A1 2732/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.